Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.
Study Type
OBSERVATIONAL
Enrollment
50
University Hospital Tübingen, Center for Neurology
Tübingen, Germany
Identifying cognitive affected domains by using CANTAB
Number of SPG4 patients with affections in the examined cognitive domains by using CANTAB
Time frame: day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.